26/07/2019 CARA SHORT 22.70 23.25
NASDAQ:CARA Has been consolidating for over 5 years now and is flirting with its ATH. The promising biotech company only has a market cap of $1B which makes a 5x move very easy and fast. This is more of a longer-term play and can increase well over 5x Stock may dip before the meteoric rise but hard to say with earnings coming first week of August. Thank you...
Cara Therapeutics is back on the strong resistance line that has been tested 4 times. Only once, in June 2017, was this briefly broken after FDA breakthrough therapy designation. CR845 reduces itching in patients with chronic liver insufficiency. This brought in June 2018 3 large pharmaceutical companies on the plan, who wanted to market this product against once...
I think we may have topped out for now. If you are not in a bullish position right now, perhaps it is wise to hold until resistance is broken, or wait for it to retrace to the 50MA. Indicators show that we're a tiny tad extended atm. Take a look at ZYNE, if CBD Pharma is your game. Just my 2 cents. It's free. Trade with caution.
finance.yahoo.com finance.yahoo.com So what Any time a clinical-stage biotech announces positive results for its lead candidate, it's good news. But today's results are especially great for Cara for several reasons. The improvement in itching for patients receiving Korsuva was off the charts. The key metric in determining statistical significance in clinical...
Cara Therapeutics was flagged on friday due to the exceptionally high amount of options traded, over 340% above the average volume. NASDAQ:CARA disappointed investors with first quarter results with a higher loss than expected, but the company has $156 million in cash available to continue to develop new Cannabinoid drugs. Cara specialises in the development of...
I have a Aug put sale because the IV is 150%, the strike price is at resistance and the stock is on an uptrend. If the price gaps in this red box (Or below $17.20), I will begin to be nervous.
- Broke the triangle channel to get a support at 14.10$. - Forming a hammer may be followed by a confirmation the next day - The target is about 18i$h
$CARA Therapeutics looks to be a good buy choice for the Tuesday market open. For information on how to access the Megalodon indicator, just send me a message!
Seems like we are the beginning stages of an IHS failure
Just wishing for something here. Planting good thoughts.
Can that be true? Will we see a longterm breakout? Or will we see a 4x-Top? Trigger for both szeanrios is the neckline of the huge H&S - the present tradingmark!
I did a write-up on Seeking Alpha on CARA breaking down where the company will be in the future (about 6 - 9 months). I am adding this stock into my portfolio. However, I am expecting the price to drop somewhat and am looking to add in positions as the price moves lower. The more CARA falls, the more I will add in.
Cara is one of many unreliable weed stocks that many follow but the good news for you is that it is on a uproar! Cara has been down for the last couple weeks but it has made its way back to +0>13% in the last couple days. Like many weed stocks they fluctuate because of the shareholders within the stock are untrained and new to the stock market. This is where you...